Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial - cnbc.com
Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.... Read More
Source: CNBC
Published: 2026-09-30T14:15:01Z
Author: Annika Kim Constantino